The ARL6IP4 Knockout HeLa Polyclonal Cells provide a targeted loss-of-function model generated through CRISPR/Cas9-mediated gene disruption of the ARL6IP4 locus in the HeLa cell background. This polyclonal knockout cell population enables researchers to study the functional consequences of ARL6IP4 depletion without the clonal variability inherent to single-cell-derived lines. By disrupting ARL6IP4 across a heterogeneous cell pool, this product retains biological complexity while offering a robust tool for probing gene function in nucleocytoplasmic transport and ciliary trafficking pathways.
HeLa cells, derived from a human cervical adenocarcinoma, are one of the most extensively utilized immortalized epithelial cell lines in biomedical research. Their widespread adoption stems from their rapid proliferation, genetic tractability, and well-characterized signaling networks, making them a preferred host for studying cancer biology, intracellular trafficking, and signal transduction. The epithelial origin of HeLa cells further enables investigation of polarity-dependent processes, including ciliogenesis under appropriate culture conditions.
ARL6IP4 interacts with ADP-ribosylation factor-like 6 (ARL6), a GTPase governing intracellular transport, ciliary trafficking, and nucleocytoplasmic shuttling. It associates with importin beta and Ran GTPase, positioning it at the nexus of nuclear import and ciliary protein delivery. By modulating ARL6, ARL6IP4 influences hedgehog signaling component localization to the cilium, affecting Gli transcription factor activity. The pathway involves importin alpha/beta, NTF2, and hedgehog ligands.
In the HeLa cell context, ARL6IP4 knockout holds particular significance for deciphering how disruptions in nucleocytoplasmic transport and ciliary trafficking intersect with cancer cell pathophysiology. HeLa cells exhibit aberrant proliferation and signaling, and ARL6IP4 loss may alter the distribution of nuclear and cytoplasmic factors, potentially affecting cell cycle progression or responsiveness to mitogenic stimuli. Moreover, studying ARL6IP4 in this adenocarcinoma model can shed light on the role of ciliary-mediated hedgehog signaling in cervical cancer progression, as this pathway is frequently dysregulated in neoplasms.
Applications include dissecting ARL6-mediated trafficking, nucleocytoplasmic shuttling via BrdU import, and ciliary length measurement with Gli reporter assays. Standard validation by western blotting, immunofluorescence, co-immunoprecipitation, and confocal microscopy is straightforward. These cells serve as a powerful loss-of-function tool for studying cancer signaling and ciliary biology. For additional information, please contact Ascent Research.
